LYMA accelerates US expansion after record year
British brand LYMA has accelerated its expansion in the United States following a strong first full year in the market.
The company entered the US in 2025 with the launch of the LYMA Laser PRO, an at-home skincare device positioned around clinical-grade technology.
That launch contributed to a record financial performance, with the female-founded MedTech business reporting $48 million in revenue and $7 million in EBITDA for the year ending 31 December 2025.
As part of its US growth strategy, LYMA has now introduced a dedicated US website and concierge service, along with new instalment payment options, including flexible plans and the ability for eligible customers to use HSA and FSA funds.
A retail partnership with department store Bloomingdale’s is also scheduled to launch in the summer.
It comes as the US has quickly become LYMA’s largest market, accounting for more than 70% of global sales.
Direct-to-consumer US sales in the first quarter of 2026 have also tripled year-on-year.
Lucy Goff, founder and CEO of LYMA, said: "A year ago, we launched the LYMA Laser PRO in the US with the most rigorous science ever published behind an at-home device, and the most extraordinary waitlist we had ever seen.
"What the year has delivered - in revenue, in clinical recognition, in the stories our customers and industry experts share with us - has surpassed even our most ambitious projections.
"The US has not just adopted LYMA; it has made it its own. We are only at the beginning of what we intend to build in the US."
In January, the brand appointed Nicole Fein as US Growth Officer, its first c-suite hire in the region. She is responsible for leading B2B expansion, including professional channels, wholesale, and distributor partnerships.
Founded in 2018, LYMA was inspired by Goff’s personal health experience following septicaemia after the birth of her daughter in 2012. The company initially launched with a supplement and later expanded into devices with the LYMA Laser PRO. In 2024, it entered the topical skincare category with a serum and cream.
The company is set to expand further in May with the launch of a new product described as a "four-dimensional gut formula", marking its entry into a new category.
